Review
Open access
Sep 2026
Advancing therapies for HER2-positive metastatic breast cancer: Navigating a wealth of treatment options.
The therapeutic landscape of HER2-positive metastatic breast cancer (HER2-positive mBC) has been transformed by increasingly effective HER2-directed therapies. Following the establishment of trastuzumab and pertuzumab as first-line standard treatment, highly active antibody-drug conjugates (ADCs), particularly trastuzu...
M. Palleschi, A. Viansone, Filippo Merloni et al.
· Cancer Treatment Reviews · 0 citations